Interferon lambda 4 variant rs12979860 is not associated with RAV NS5A Y93H in hepatitis C virus genotype 3a

Hepatology

Volumn 64, Issue 4, 2016, Pages 1377-1378

  Pedergnana, Vincent ^a   Smith, David ^b   Klenerman, Paul ^b   Barnes, Eleanor ^b   Spencer, Chris C A ^a   Ansari, M Azim ^b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; LAMBDA INTERFERON; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; VIRAL PROTEIN;

GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 3; HEPATITIS C VIRUS GENOTYPE 3A; HUMAN; LETTER; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; CHRONIC HEPATITIS C; GENETICS; HEPACIVIRUS;

ANTIVIRAL AGENTS; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84963877977     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28533     Document Type: Letter

References (3)

1. Peiffer KH, Sommer L, Susser S, Vermehren J, Herrmann E, Doring M, et al. Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3. Hepatology 2016;63:63-73.
2. Foster GR, Pianko S, Brown A, Forton D, Nahass RG, George J, et al. Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infection. Gastroenterology 2015;149:1462-1470.
3. Bonsall D, Ansari M, Ip C, Trebes A, Brown A, Klenerman P, et al. ve-SEQ: robust, unbiased enrichment for streamlined detection and whole-genome sequencing of HCV and other highly diverse pathogens [version 1; referees: 1 approved]. 2015. Available at: http://f1000research.com/articles/4-1062/v1. Accessed on March 17, 2016.